---
title: "Pre-market hot trades in US stocks: Evogene pre-market down 10.84%; Julong pre-market down 9.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292876330.md"
description: "Evogene pre-market down 10.84%; Julong pre-market down 9.95%; Agape ATP pre-market up 51.50%; AtaiBeckley pre-market up 49.47%; The Growhub pre-market up 35.05%"
datetime: "2026-07-16T08:32:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292876330.md)
  - [en](https://longbridge.com/en/news/292876330.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292876330.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Evogene pre-market down 10.84%; Julong pre-market down 9.95%

**Popular Pre-Market Trades in US Stocks**

Evogene is down 10.84% in pre-market trading. Based on recent key news:

1.  On July 15, AgPlenus launched a predictive model for antifungal efficacy, expanding the capabilities of Evogene's platform. This move aims to improve the development efficiency of fungicide products but failed to immediately boost market confidence, leading to a decline in stock price. Source: AgPlenus announcement

2.  On July 15, Evogene faces geopolitical instability risks in the Middle East, which may affect its business operations. Investor concerns over regional conflicts have intensified, further pressuring the stock price. Source: Evogene report

3.  On July 15, Evogene relies on third parties for research activities, and failure to complete them on time may lead to project delays. Market concerns about its operational capabilities have increased, impacting stock performance. Source: Evogene report. The global fungicide market has an annual scale of $22 billion.

Julong is down 9.95% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

**Top Gainers in Pre-Market Trading in US Stocks**

Agape ATP is up 51.50% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

AtaiBeckley is up 49.47% in pre-market trading. Based on recent key news:

1.  On July 15, Bloomberg reported that Eli Lilly is in talks to acquire AtaiBeckley, with an announcement expected this week. This news drove AtaiBeckley's stock price up 66% after hours.

2.  On July 16, Investing.com reported that Eli Lilly is negotiating to acquire AtaiBeckley at a premium, with its market value climbing to approximately $2 billion, further strengthening its neuroscience product portfolio.

3.  On July 16, AtaiBeckley's core drug BPL-003 received FDA "Breakthrough Therapy" designation, increasing market interest in psychedelic drugs. There is a noticeable influx of capital due to rising interest in the psychedelic drug market.

The Growhub is up 35.05% in pre-market trading. Based on recent key news:

1.  On July 15, The Growhub Ltd. released important information through the EDGAR system of the U.S. Securities and Exchange Commission. The release of this information may trigger positive market expectations for the company's future development, significantly boosting the stock price. Source: EDGAR system

2.  No other relevant significant news recently. Market interest in tech stocks has increased

### Related Stocks

- [EVGN.US](https://longbridge.com/en/quote/EVGN.US.md)
- [JLHL.US](https://longbridge.com/en/quote/JLHL.US.md)
- [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md)
- [ATAI.US](https://longbridge.com/en/quote/ATAI.US.md)
- [TGHL.US](https://longbridge.com/en/quote/TGHL.US.md)

## Related News & Research

- [Evogene Updates U.S. Investors With New August 2026 Presentation](https://longbridge.com/en/news/297200334.md)
- [Evogene Chief Development Officer Gabi Tarcic acquires 1,129 shares for $677.40](https://longbridge.com/en/news/297082172.md)
- [ISS, Glass Lewis urge Evogene shareholders to back management slate over dissidents seeking board overhaul at Sept. 4 vote](https://longbridge.com/en/news/296901808.md)
- [Julong Holding files Form 3 initial beneficial ownership statement for director Zhang Xitian](https://longbridge.com/en/news/296773029.md)
- [Altria Group (NYSE:MO) Stock Price Up 1.5% Following Dividend Announcement](https://longbridge.com/en/news/297368761.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**